Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure-Reference-Cited by-同舟云学术

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure

Published:2019-03-26 Issue:12 Volume:321 Page:1176
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Yau Terrence M.¹²,Pagani Francis D.³,Mancini Donna M.⁴,Chang Helena L.⁴,Lala Anuradha⁴,Woo Y. Joseph⁵,Acker Michael A.⁶,Selzman Craig H.⁷,Soltesz Edward G.⁸,Kern John A.⁹,Maltais Simon¹⁰,Charbonneau Eric¹¹,Pan Stephanie⁴,Marks Mary E.⁴,Moquete Ellen G.⁴,O’Sullivan Karen L.⁴,Taddei-Peters Wendy C.¹²,McGowan Lydia K.³,Green China⁹,Rose Eric A.¹³,Jeffries Neal¹²,Parides Michael K.¹⁴,Weisel Richard D.¹²,Miller Marissa A.¹²,Hung Judy¹⁵,O’Gara Patrick T.¹⁶,Moskowitz Alan J.⁴,Gelijns Annetine C.⁴,Bagiella Emilia⁴,Milano Carmelo A.¹⁷,

Affiliation:

1. Peter Munk Cardiac Centre, Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

2. Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada

3. Department of Cardiac Surgery, University of Michigan, Ann Arbor

4. International Center for Health Outcomes and Innovation Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York

5. Department of Cardiothoracic Surgery, Stanford University, Stanford, California

6. Division of Cardiovascular Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia

7. Division of Cardiothoracic Surgery, University of Utah School of Medicine, Salt Lake City

8. Thoracic & Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio

9. Department of Surgery, University of Virginia, Charlottesville

10. Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota

11. Department of Cardiac Surgery, Québec City Heart and Lung Institute, Québec City, Québec, Canada

12. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland

13. Icahn School of Medicine at Mount Sinai, New York, New York

14. Department of Cardiothoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York

15. Division of Cardiology, Massachusetts General Hospital, Boston

16. Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts

17. Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/article-pdf/321/12/1176/17858165/jama_yau_2019_oi_190024.pdf

Reference17 articles.

1. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? an analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.;Suncion;Circ Res,2014

2. Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis.;Xu;Can J Cardiol,2014

3. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.;Karantalis;Circ Res,2014

4. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.;Heldman;JAMA,2014

5. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.;Ascheim;Circulation,2014

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recipients: Results of the uSTOP LVAD BLEED pilot study;JHLT Open;2024-02

2. Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence;Frontiers in Physiology;2024-01-09

3. Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome;JTCVS Open;2023-12

4. Mesenchymal STRO-1/STRO-3⁺ precursor cells for the treatment of chronic heart failure with reduced ejection fraction;Future Cardiology;2023-11-07

5. Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation;Transplantation;2023-10-24